AZN
Astrazeneca
$169.64
+$0.37 (+0.22%)Jul 27, 2026
Key metrics
The numbers that frame AZN today
- Market cap
- $262.94B
- P/E (TTM)
- 25.2
- EV / FCF
- 27.2
- Gross margin
- 81.9%
- EV / Sales
- 4.7
- ROIC
- 29.2%
- Div yield
- 2.48%
- Debt / equity
- 0.6
- 52wk Low
- $139.55
- 52wk High
- $210.49
Growth
Revenue and earnings trend for AZN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about AZN
Is Astrazeneca a good buy?
Yes. Astrazeneca has excellent quality and strong momentum. Both signals support the setup. Growth looks weak, a caveat that does not overturn the setup. We think Astrazeneca is selling at a fair price.
What is the market capitalization of AZN?
Astrazeneca's market capitalization is $262.94B.
What is the P/E ratio for AZN stock?
Astrazeneca's current P/E ratio is 25.2.
What is the 52-week high for AZN stock?
The 52-week high for Astrazeneca is $210.49. The current close of $169.64 is 19.4% below that high.
What is the 52-week low for AZN stock?
The 52-week low for Astrazeneca is $139.55. The current close of $169.64 is 21.6% above that low.
Does AZN stock pay dividends?
Astrazeneca pays a dividend. The latest dividend per share in the company data is $4.21, which implies a yield of 2.48% based on the current close.
What is the Debt / Equity ratio for AZN?
Astrazeneca's Debt / Equity ratio is 0.64.